Regarding to the titer of ACPA or RF toward radiographic progression in patients with RA, the opposite results have been published in the literature17–20,39–41 The disagreement might be induced by the difference or presence/absence of DMARDs treatments of the subjects at entry. The gene discussed is PRTN3; the disease is rheumatoid arthritis.